• Category: Research
Lutein shows potential as myopia management supplement
Research

Lutein shows potential as myopia management supplement

Preliminary RCT data highlights preservation of choroidal thickness in children taking lutein supplements.
Could RAR determine cataract risk?
Research

Could RAR determine cataract risk?

Cost-effective biomarker emerges as potential tool for risk assessment and early prevention in cataract patients.
Dual GIP-GLP-1 RA shows superior efficacy in lowering POAG, OHT risk
Research

Dual GIP-GLP-1 RA shows superior efficacy in lowering POAG, OHT risk

Tirzepatide consistently reduced the risk of glaucomatous disease compared to GLP-1 RAs, even among high-risk patients.
Iron overload may increase glaucoma risk
Research

Iron overload may increase glaucoma risk

Study proposes that systemic iron dysregulation is a modifiable risk factor for glaucomatous disease.
Seasonal variations play major role in CSC development
Research

Seasonal variations play major role in CSC development

Observed increased incidence of CSC in spring and autumn provide potential insights into the disease’s pathogenesis.
HOYA reports 6-month data on MiYOSMART iQ spectacle lenses for pediatric myopia
Research

HOYA reports 6-month data on MiYOSMART iQ spectacle lenses for pediatric myopia

Interim results find advanced lens and D.I.M.S. triple enhanced design tech to be twice as effective in controlling axial elongation and disease progression.
Reducing chronic inflammation minimizes AMD-linked vision loss
Research

Reducing chronic inflammation minimizes AMD-linked vision loss

Mouse model demonstrates role of NLRP3 in AMD pathology and highlights potential therapeutic approaches.
Researchers develop clinical decision tool for GA treatment
Research

Researchers develop clinical decision tool for GA treatment

Atrophy Advisor could help clinicians determine the optimal therapeutic approach for GA patients.
First real-world data shows early promise of high-dose aflibercept for wet AMD
Research

First real-world data shows early promise of high-dose aflibercept for wet AMD

Eight-week findings from the SPECTRUM observational study indicate a safety profile consistent with prior evaluations.
Study demonstrates accuracy of new platform for comparing AI-based DR screening systems
Research

Study demonstrates accuracy of new platform for comparing AI-based DR screening systems

New testing platform allows for comparison of effectiveness and fairness in commercial AI systems.
Pseudoexfoliation glaucoma is most prevalent among Indigenous populations in the US
Research

Pseudoexfoliation glaucoma is most prevalent among Indigenous populations in the US

Study finds American Indian or Alaska Native patients are impacted by PXG and PG nearly threefold more than the general U.S. population.
Cannabis implicated in ocular inflammatory disease development
Research

Cannabis implicated in ocular inflammatory disease development

Cannabis use associated with higher risk of developing uveitis and other posterior segment diseases.
Conflicting evidence surrounds astigmatism's role in myopia
Research

Conflicting evidence surrounds astigmatism's role in myopia

Study highlights need for further investigation into the impact of astigmatism on myopia onset and progression.
New QLOSI safety data supports drop as pupil selective for presbyopia
Research

New QLOSI safety data supports drop as pupil selective for presbyopia

Head-to-head trial finds pilocarpine 0.4% resulted in no significant changes in ciliary muscle or lens thickness following dosing.
Could high HDL levels lead to lower DR risk?
Research

Could high HDL levels lead to lower DR risk?

Study emphasizes importance of monitoring HDL levels in patients with diabetic retinopathy.
HPMC injections for hypotony show vision restoration potential
Research

HPMC injections for hypotony show vision restoration potential

New research demonstrates effectiveness of intravitreal injections in improving vision, IOP, and axial length restoration after 12 months.
Beta-zone PPA may be major glaucoma disease marker for Black patients
Research

Beta-zone PPA may be major glaucoma disease marker for Black patients

Beta-zone PPA was linked with RNFL thinning, suggesting it may be a feature of glaucomatous change.
GLP-1 use may lower long-term DME, DR risk
Research

GLP-1 use may lower long-term DME, DR risk

Study highlights protective effect of GLP-1 RAs against ocular complications of diabetes and disparities for racialized patients
Study identifies key risk factors for punctate inner choroidopathy patients
Research

Study identifies key risk factors for punctate inner choroidopathy patients

Study identifies key risk factors for punctate inner choroidopathy patients.
Does YAG capsulotomy increase DR risk?
Research

Does YAG capsulotomy increase DR risk?

Study highlights need for close monitoring of NPDR patients after posterior capsule opacification treatment.